Goldman Sachs acquires United Capital in its largest deal in 20 years

By Nikita Chaurasia  Date: 2019-05-18

Goldman Sachs acquires United Capital in its largest deal in 20 years
  • With the proposed acquisition, Goldman Sachs aims to further consolidate its wealth-management business.
     
  • The move comes under the company’s ongoing effort to diversify itself away from trading; a troubled section of the bank in past few years.

The Goldman Sachs Group, Inc., (Goldman Sachs), a renowned American multinational investment banking firm, has reportedly announced its biggest acquisition in over 20 years, wherein it has procured California-based asset management boutique firm United Capital.

Reports cite, through the proposed acquisition, the New York based investment banking firm aims to further consolidate its wealth-management business. The move supposedly comes under the company’s ongoing effort to diversify itself away from trading; a troubled section of the bank over the past few years.

According to reports, the proposed deal is the company’s biggest since its acquisition of Spear Leeds in 2000, conducted by Hank Paulson; another investment banker. The latest deal is intended to fill up Goldman’s wealth offering and draw in more recurring form of revenue to a firm that still brings approximately over 60% of its top line through private investing & trading activities.

Major acquisitions such as these have become increasingly rare across the post-crisis era as more and more Wall Street firms are focusing on ways to avoid the wrath of politicians as well as regulators.

The CEO of Goldman Sachs, David Solomon stated that the proposed deal will accelerate the company’s wealth management strategy by widening its reach. Solomon further added that the said strategy would allow more clients to access the investment capabilities & intellectual capital of Goldman Sachs.

Under the terms of the agreement, the founder & CEO of United Capital, Joe Duran would be joining             Goldman Sachs. Moreover, United’s employees and over 220 financial advisors throughout the U.S. would also be coming onboard Goldman Sachs.

The proposed acquisition would reportedly be costing Goldman Sachs approximately $750 million.

 

Source Credit: https://edition.cnn.com/2019/05/16/investing/goldman-sachs-acquisition-united-capital/index.html

https://www.businessinsider.com/united-capital-goldman-sachs-deal-2019-5?IR=T&_ga=2.152017209.1416937372.1557999837-1007959535.155799983

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...

LinkedIn confirms launch of a social audio platform to rival Clubhouse

LinkedIn confirms launch of a social audio platform to rival Clubhouse

By Nikita Chaurasia

LinkedIn, the popular employment-oriented online service, has confirmed that it is testing a social audio experience in its app which could offer users with better connectivity in their networks. Although several social media giants such as Twitter ...

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

By Nikita Chaurasia

Pfizer Inc., an American multinational pharmaceutical corporation, has recently announced to have started the early phase trials for its oral antiviral drug for Coronavirus. The company revealed that first phase trials of the experimental drug, PF-07...